Wangxiong Hu[Author] - Search Results

Year	Number of Results
2012	1
2014	4
2015	2
2016	4
2017	4
2018	3
2019	6
2020	5
2021	9
2022	4
2023	2
2024	0

1

Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.

Shao Y, Xu K, Zheng X, Zhou B, Zhang X, Wang L, Sun Y, Li D, Chen T, Wang J, Yu S, Sun L, Xu X, Dai S, Gao H, Ruan G, Liu W, Cai X, Zhu T, Qi L, Chen J, Hu W, Weng X, Zhu Y, Xiang X, Hu Z, Li J, Chen L, Shao J, Zheng S, Guo T. Shao Y, et al. Among authors: hu w. Cancer Commun (Lond). 2022 Feb;42(2):164-169. doi: 10.1002/cac2.12240. Epub 2021 Dec 4. Cancer Commun (Lond). 2022. PMID: 34862750 Free PMC article. No abstract available.

2

miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4.

Jiang H, Su Z, Hu W, Yuan X, Yu T, Yang J, Xiao X, Zheng S, Lin B. Jiang H, et al. Among authors: hu w. OMICS. 2023 May;27(5):215-226. doi: 10.1089/omi.2023.0046. OMICS. 2023. PMID: 37196148

3

Subtyping of microsatellite instability-high colorectal cancer.

Hu W, Yang Y, Qi L, Chen J, Ge W, Zheng S. Hu W, et al. Cell Commun Signal. 2019 Jul 22;17(1):79. doi: 10.1186/s12964-019-0397-4. Cell Commun Signal. 2019. PMID: 31331345 Free PMC article.

4

Deciphering molecular properties of hypermutated gastrointestinal cancer.

Hu W, Yang Y, Ge W, Zheng S. Hu W, et al. J Cell Mol Med. 2019 Jan;23(1):370-379. doi: 10.1111/jcmm.13941. Epub 2018 Oct 31. J Cell Mol Med. 2019. PMID: 30381870 Free PMC article.

5

A pretreatment transcriptomic signature that predicts outcomes of immunotherapy in melanoma.

Hu J, Liu B, Hu W, Yang Y. Hu J, et al. Among authors: hu w. Heliyon. 2022 Dec 23;8(12):e12648. doi: 10.1016/j.heliyon.2022.e12648. eCollection 2022 Dec. Heliyon. 2022. PMID: 36619423 Free PMC article.

6

Flexible microRNA arm selection in rice.

Hu W, Wang T, Yue E, Zheng S, Xu JH. Hu W, et al. Biochem Biophys Res Commun. 2014 May 9;447(3):526-30. doi: 10.1016/j.bbrc.2014.04.036. Epub 2014 Apr 15. Biochem Biophys Res Commun. 2014. PMID: 24746469

7

Pan-organ transcriptome variation across 21 cancer types.

Hu W, Yang Y, Li X, Zheng S. Hu W, et al. Oncotarget. 2017 Jan 24;8(4):6809-6818. doi: 10.18632/oncotarget.14303. Oncotarget. 2017. PMID: 28036280 Free PMC article.

8

Stromal score is a promising index in tumor patients' outcome determination.

Xu X, Xu Y, Hu W, Hong W, Wang Y, Zhang X, Fan X, Wang T, Lou H, Yang Y, Qian J. Xu X, et al. Among authors: hu w. Heliyon. 2023 Nov 20;9(11):e22432. doi: 10.1016/j.heliyon.2023.e22432. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034609 Free PMC article.

9

HomeoboxC6 promotes metastasis by orchestrating the DKK1/Wnt/β-catenin axis in right-sided colon cancer.

Qi L, Chen J, Zhou B, Xu K, Wang K, Fang Z, Shao Y, Yuan Y, Zheng S, Hu W. Qi L, et al. Among authors: hu w. Cell Death Dis. 2021 Apr 1;12(4):337. doi: 10.1038/s41419-021-03630-x. Cell Death Dis. 2021. PMID: 33795652 Free PMC article.

10

Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer.

Wang K, Yang Y, Zheng S, Hu W. Wang K, et al. Among authors: hu w. Onco Targets Ther. 2022 Jul 9;15:761-769. doi: 10.2147/OTT.S369670. eCollection 2022. Onco Targets Ther. 2022. PMID: 35847380 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year